Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 9, 2014, Pages 3444-3449

  Winnier, Diedre ^a   Norton, Luke ^a   Kanat, Mustafa ^b   Arya, Ruth ^a   Fourcaudot, Marcel ^a   Hansis Diarte, Andrea ^a   Tripathy, Devjit ^a   De Fronzo, Ralph A ^a   Jenkinson, Christopher P ^a   Abdul Ghani, Muhammad ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b ISTANBUL MEDIPOL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; PROGLUCAGON; GLUCAGON; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; COMBINED GLUCOSE INTOLERANCE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISORDERS OF CARBOHYDRATE METABOLISM; EUGLYCEMIC HYPERINSULINEMIC CLAMP; FASTING GLUCOSE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN MEDIATED GLUCOSE UPTAKE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET DISEASE; SENSITIVITY ANALYSIS; TIME SERIES ANALYSIS; TWO HOUR GLUCOSE BLOOD LEVEL; CLINICAL TRIAL; DIET RESTRICTION; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; METABOLISM; MEXICAN AMERICAN; MIDDLE AGED; PROCEDURES; REFERENCE VALUE; SKELETAL MUSCLE; STANDARDS; STATISTICAL MODEL; VALIDATION STUDY;

ADULT; BLOOD GLUCOSE; FASTING; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; LINEAR MODELS; MALE; MEXICAN AMERICANS; MIDDLE AGED; MUSCLE, SKELETAL; PREDIABETIC STATE; REFERENCE VALUES;

EID: 84907211102     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2886     Document Type: Article

References (25)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20: 1183-1197.
2. Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycemia: The current status on definition and intervention. Diabet Med. 2002;19: 708-723.
3. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78: 305-312.
4. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, De- Fronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006; 55: 1430-1435.
5. Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006;29: 1909-1914.
6. Wasada T, Kuroki H, Katsumori K, Arii H, Sato A, Aoki K.Whoare more insulin resistant people with IFG or people with IGT? Diabetologia. 2004;47: 758-759.
7. Faerch K, Vaag A, Holst JJ, Glümer C, Pedersen O, Borch-Johnsen K. Impaired fasting glycaemia vs impaired glucose tolerance: Similar impairment of pancreatic - and - cell function but differential roles of incretin hormones and insulin action. Diabetologia. 2008;51: 853-861.
8. Piche ME, Despres JP, Pascot A, et al. Impaired fasting glucose vs glucose intolerance in pre-menopausal women: Distinct metabolic entities and cardiovascular disease risk? Diabet Med. 2004;21: 730-737.
9. Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004;53: 1549-1555.
10. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova- Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: The risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003;26: 868-874.
11. Carnevale Schianca GP, Rossi A, Sainaghi PP, Maduli E, Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: Importance of insulin secretion and resistance. Diabetes Care. 2003;26: 1333-1337.
12. Snehalatha C, Ramachandran A, Sivasankari S, Satyavani K, Vijay V. Insulin secretion and action show differences in impaired fasting glucose and in impaired glucose tolerance in Asian Indians. Diabetes Metab Res Rev. 2003;19: 329-332.
13. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes. 1999;48: 2197-2203.
14. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med. 2000;17: 433-440.
15. Kanat M, Mari A, Norton L, et al. Distinct - cell defects in impaired fasting glucose and impaired glucose tolerance. Diabetes. 2012;61: 447-453.
16. Kanat M, Norton L, Winnier D, Jenkinson C, DeFronzo RA, Abdul- Ghani MA. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose. Acta Diabetol. 2011;48: 209-217.
17. Kim SH, Reaven GM. Isolated impaired fasting glucose and peripheral insulin sensitivity: Not a simple relationship. Diabetes Care. 2008;31: 347-352.
18. Bock G, Chittilapilly E, Basu R, et al. Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose, role of increased rates of gluconeogenesis. Diabetes. 2007;56: 1703-1711.
19. Abdul-Ghani MA, DeFronzo RA. Pathophysiology of prediabetes. Curr Diab Rep. 2009;9: 193-199.
20. Jani R, Molina M, Matsuda M, et al. Decreased non-insulin-dependent glucose clearance contributes to the rise in fasting plasma glucose in the nondiabetic range. Diabetes Care. 2008;31: 311-315.
21. Diamond MP, Thornton K, Connolly-Diamond M, Sherwin RS, DeFronzo RA. Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose tolerance. J Soc Gynecol Invest. 1995;2: 708-715.
22. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care. 2000;23: 171-175.
23. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care. 2007;30: 1544-1548.
24. Abdul-Ghani MA, Stern MP, Lyssenko V, Tuomi T, Groop L, De- Fronzo RA. Minimal contribution of fasting hyperglycemia to the incidence of T2DM in subjects with normal 2 hour plasma glucose. Diabetes Care. 2010;33: 557-561.
25. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. The shape of plasma glucose concentration curve during OGTT predicts future risk of type 2 diabetes. Diab Metab Res Rev. 2010; 26: 280-286.